|
COPB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.744290E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.422690E-03 |
| Normal-vs-Stage2 |
1.441400E-01 |
| Normal-vs-Stage3 |
1.317130E-03 |
| Normal-vs-Stage4 |
5.170200E-01 |
| Stage1-vs-Stage2 |
6.717000E-01 |
| Stage1-vs-Stage3 |
4.368000E-01 |
| Stage1-vs-Stage4 |
1.316200E-01 |
| Stage2-vs-Stage3 |
3.749400E-01 |
| Stage2-vs-Stage4 |
4.615400E-01 |
| Stage3-vs-Stage4 |
5.586100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.841600E-03 |
| Normal-vs-AfricanAmerican |
1.978430E-04 |
| Normal-vs-Asian |
1.680630E-01 |
| Caucasian-vs-AfricanAmerican |
7.389600E-02 |
| Caucasian-vs-Asian |
8.063000E-01 |
| AfricanAmerican-vs-Asian |
6.036200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.195300E-04 |
| Normal-vs-Female |
2.421400E-01 |
| Male-vs-Female |
1.815020E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.138400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.721540E-02 |
| Normal-vs-Age(61-80Yrs) |
2.084800E-03 |
| Normal-vs-Age(81-100Yrs) |
1.9972099999932E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.134200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.676600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.278200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.279200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.261400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.883680E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.672400E-01 |
| Normal-vs-Grade 2 |
3.395400E-03 |
| Normal-vs-Grade 3 |
9.622400E-04 |
| Normal-vs-Grade 4 |
4.292600E-01 |
| Grade 1-vs-Grade 2 |
2.362600E-01 |
| Grade 1-vs-Grade 3 |
1.857170E-01 |
| Grade 1-vs-Grade 4 |
7.260800E-01 |
| Grade 2-vs-Grade 3 |
5.559800E-01 |
| Grade 2-vs-Grade 4 |
2.974400E-01 |
| Grade 3-vs-Grade 4 |
1.788200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.581600E-02 |
| Normal-vs-ccB subtype |
2.539600E-02 |
| ccA subtype-vs-ccB subtype |
9.171400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.385800E-02 |
| Normal-vs-N1 |
5.051200E-01 |
| N0-vs-N1 |
8.839900E-02 |
|
|
